EDITORIAL
Published on 09 Feb 2024
Editorial: Repurposing β-blockers for non-cardiovascular diseases
doi 10.3389/fphar.2024.1372317
- 1,097 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Repurposing β-blockers for non-cardiovascular diseases
Repurposing β-blockers for non-cardiovascular diseases
3,945
Total downloads
14k
Total views and downloads
Articles
MINI REVIEW
Published on 09 Jan 2024
Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
doi 10.3389/fphar.2023.1325050
- 2,761 views
- 5 citations
ORIGINAL RESEARCH
Published on 27 Nov 2023
Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study
doi 10.3389/fphar.2023.1294297
- 3,079 views
- 4 citations
ORIGINAL RESEARCH
Published on 26 Oct 2023
Association between the β-blocker use and patients with sepsis: a cohort study
doi 10.3389/fmed.2023.1272871
- 3,041 views
- 6 citations
ORIGINAL RESEARCH
Published on 19 May 2023
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
doi 10.3389/fphar.2023.1137791
- 1,752 views
- 1 citation
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Neuropharmacology
Cardiovascular and Smooth Muscle Pharmacology
Inflammation Pharmacology
Participating Journals
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore